Matches 1 - 50 out of 89 1 2 >


Match Document Document Title
US20140072645 DOSAGE FORMS FOR ORAL ADMINISTRATION AND METHODS OF TREATMENT USING THE SAME  
The invention relates to dosage forms that provide prolonged therapy. In particular, the invention relates to dosage forms including various pluralities of drug-containing resin particles. The...
US20110033508 INJECTABLE MICROSPHERES FOR DERMAL AUGMENTATION AND TISSUE BULKING  
The present invention relates to elastic, hydrophilic and substantially spherical microspheres useful for dermal augmentation and tissue bulking. The invention provides injectable compositions...
US20110104212 POLYMERIC COMPOSITIONS WITH ENHANCED SALINE HOLDING CAPACITY AND THEIR METHOD OF PREPARATION AND USE  
Cross-linked polyelectrolyte polymers that absorb 60-fold or more, including greater than 60-fold, greater than 70-fold, greater than 80-fold, greater than 90-fold, greater than 100-fold, or...
US20120171151 MASS SPECTROMETRIC QUANTITATION ASSAY FOR METABOLITES OF LEFLUNOMIDE  
Methods are described for determining the amount of metabolites of leflunomide in a sample. More specifically, mass spectrometric methods are described for detecting and quantifying teriflunomide...
US20120087887 Composition and Method for Arresting Blood Flow and for Forming a Persistent Microbial Barrier  
A composition and method useful in promoting healing of a bleeding wound site. The composition preferably includes a substantially anhydrous acid form of a cation exchange resin, which when...
US20110293470 CONJUGATED POLYELECTROLYTE CAPSULES: LIGHT ACTIVATED ANTIMICROBIALS  
Hollow conjugated polyelectrolyte (HCPE) microcapsules contain at least one conjugated polyelectrolyte and at least one other polyelectrolyte of complementary charge and the microcapsule has a...
US20140205558 SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS  
Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon...
US20110123604 ABSORBENT POLYMERIC COMPOSITIONS WITH VARYING COUNTERION CONTENT AND THEIR METHODS OF PREPARATION AND USE  
Cross-linked polyelectrolyte polymers with bound counterions that absorb about 20-fold or more of their mass in saline such as physiological saline a with the proviso that sodium does not exceed...
US20070248564 FORMULATION OF SODIUM POLYSTYRENE SULFONATE SUSPENSION FOR THE TREATMENT OF HYPERKALEMIA  
This invention relates to a stable, sorbitol free suspension formulation of sodium polystyrene sulfonate.
US20100028290 DISINFECTANT  
A disinfectant, especially a skin disinfectant, an antiseptic agent for open wounds and a preparation for biocidal impregnation of plants, objects or materials, especially porous objects or...
US20120070380 Ingestible salt grabber  
Disclosed herein include embodiments related to compositions, devices, computer systems, computer-implemented methods, and computer program products associated with an ingestible salt grabber.
US20110038827 ELEVATION OF THE PLASMA HDL-CHOLESTEROL LEVEL  
The present invention relates to the use of isosteviol, steviol, and related compounds for elevating the plasma HDL-cholesterol level. The invention furthermore relates to the use of these...
US20150182555 PHARMACEUTICAL COMPOSITION CONTAINING PHOSPHATE BINDING POLYMER  
The present invention relates to a fast dissolving tablet comprising a therapeutically effective amount of a phosphate binding polymer, such as sevelamer or pharmaceutically acceptable salt or...
US20120093759 Medical Devices, Wound Dressings, and Methods for Dressing Wounds  
Medical devices, wound dressings, and methods of dressing wounds are described. Devices and methods using silicone and pharmaceutically active agents are described. Devices including covers and...
US20080226579 Novel Resinate Complex of S-Clopidogrel and Production Method Thereof  
The present invention is a novel resinate complex of (+)-clopidogrel optical isomer, wherein the (+)-clopidogrel isomer is bounded to a water-soluble cation exchange resin having sulfonic acid...
US20090252794 TABLET  
The present invention provides a novel tablet with improved tablet appearance and improved swallowability. The tablet contains a pharmaceutically acceptable anion exchange resin represented by...
US20050287107 Odor control device  
An odor control device can be discretely worn and used to minimize the effects of an unpleasant or offensive odor. The odor control device includes a flexible support strap or band and a fragrance...
US20120251478 Method for treatment of a glomerular disease comprising administration of anion exchange resin  
Provided is a novel prophylactic and/or therapeutic agent for glomerular disease wherein a pharmaceutically acceptable anion exchange resin, typified by colestimide, is an active ingredient thereof.
US20050013791 Cytokine-inducing material and cytokine-inducing instrument  
A cytokine-inducing material and a cytokine-inducing instrument to be used in cytokine-induction therapy and the like. More specifically speaking, a cytokine-inducing material characterized by...
US20130034607 TABLET  
The present invention provides a novel tablet with improved tablet appearance and improved swallowability. The tablet contains a pharmaceutically acceptable anion exchange resin represented by...
US20150104510 Aliphatic Amine Polymer Salts for Tableting  
The tablets, compositions and methods of the present invention, comprising a carbonate salt of an aliphatic amine polymer and s monovalent anion can prevent or ameliorate acidosis, in particular...
US20050008609 Multi-component reverse thermo-sensitive polymeric systems  
A multi-component environmentally responsive polymeric system, having at least two environmentally responsive polymeric components capable of undergoing a transition that results in a sharp...
US20130309191 COMPOUNDS FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE-ASSOCIATED DISEASE  
Disclosed are compounds of formula (I): or a pharmaceutically acceptable N-oxide, salt, hydrate, solvate, complex, bioisostere, metabolite or prodrug thereof, which are of use in the treatment of...
US20130095057 COMPOUNDS FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE-ASSOCIATED DISEASE  
Disclosed are compounds of formula (I): or a pharmaceutically acceptable N-oxide, salt, hydrate, solvate, complex, bioisostere, metabolite or prodrug thereof, which are of use in the treatment of...
US20150086501 POLYMERS FUNCTIONALIZED WITH ION-SPECIFIC RECOGNITION ELEMENTS  
Polymeric compounds containing polymer backbones functionalized with ion-specific recognition elements and methods for the use of these compounds are described herein. The polymeric compounds may...
US20050232895 Anti-viral pharmaceutical compositions  
The present invention provides antiviral compositions that comprise one or more of an ionic multivalent metal component, a cationic polymer, and a cationic surfactant. The present invention also...
US20150132245 METHOD FOR DETOXIFICATION OR MEASUREMENT OF AT LEAST ONE COMPOUND OR AT LEAST ONE FLUID IN A HOST BODY  
The present invention comprises a method for detoxification or measurement of the concentration of at least one compound in a host body, wherein said host body comprises a sorption material of at...
US20130259949 METHODS AND COMPOSITIONS FOR SELECTIVELY REMOVING POTASSIUM ION FROM THE GASTROINTESTINAL TRACT OF A MAMMAL  
The present invention provides methods and compositions for the treatment of ion imbalances using core-shell composites and compositions comprising such core-shell composites. In particular, the...
US20120201887 Pharmaceutical Formulation  
A pharmaceutical composition in the form of a tablet including a first portion and a second portion, wherein said first portion includes guaifenesin having an immediate release profile and a...
US20080044371 Taste-Masked Composition of Cationic Exchange Resin  
The present invention provides a taste-masked composition containing an active compound. The composition is taste-masked by employing a loaded polymeric matrix which is produced by incorporating...
US20090092573 Method of manufacturing a nicotine delivery product  
A method of manufacturing a nicotine delivery product comprising nicotine and a cation exchange resin. More precisely, to a method for preparing a nicotine delivery product said method comprising...
US20120148672 ABUSE RESISTANT OPIOID DRUG-ION EXCHANGE RESIN COMPLEXES HAVING HYBRID COATINGS  
A sustained release formulation for opioid drugs is described. The formulation contains an opioid-ion exchange resin complex having a hybrid coating. The hybrid coating contains a cured...
US20090162311 Agent for Prevention and/or Treatment of Glomerulopathy  
Provided is a novel prophylactic and/or therapeutic agent for glomerular disease wherein a pharmaceutically acceptable anion exchange resin, typified by colestimide, is an active ingredient thereof.
US20140154328 Pharmaceutical Composition  
The invention relates to an oral pharmaceutical composition comprising coated particles of a complex of at least one active agent with an ion-exchange resin, wherein said particles are coated with...
US20120164221 COMBINATIONS OF HMG-COA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPERLIPIDEMIA ONCE A DAY AT NIGHT  
The present invention relates to solid pharmaceutical combinations for oral administration comprising nicotinic acid or a nicotinic acid compound or mixtures thereof in an extended release form...
US20100330021 SUBSTITUTED (THIAZOL-2-YL)-AMIDE OR SULFONAMIDE AS GLYCOKINASE ACTIVATORS USEFUL IN THE TREATMENT OF TYPE 2 DIABETES  
Compounds of the formula R—NH-Q (I) provide pharmacological agents which are glucokinase activators and thus may be employed for the treatment of glucokinase mediated conditions. Accordingly, the...
US20140286891 ION BINDING POLYMERS AND USES THEREOF  
The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising potassium binding polymers and...
US20130272992 ION BINDING POLYMERS AND USES THEREOF  
The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising potassium binding polymers and...
US20130272991 ION BINDING POLYMERS AND USES THEREOF  
The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising potassium binding polymers and...
US20110206631 ION BINDING POLYMERS AND USES THEREOF  
The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising potassium binding polymers and...
US20130177520 TASTE MASKED DOSAGE FORMS OF BITTER TASTING ANTI-RETROVIRAL DRUGS  
The present invention relates to taste masked dosage forms of bitter tasting anti-retroviral drugs comprising a complex of the said anti-retroviral drug and an ion-exchange resin and one or more...
US20060165647 Immunosuppressive substance adsorbent, extracorporeal cicrulation column and method of treating cancer  
An object of this invention is to provide an adsorbent for immunosuppressive substance, which adsorbent can highly efficiently and selectively adsorb an excessive immunosuppressive substance...
US20120135060 COMPOSITIONS AND METHODS FOR CELL KILLING  
Provided herein are biocidic compositions including an ion exchange material, wherein when said material is in an environment capable of transporting H+, said ion exchange material is adapted to...
US20090175818 Poly(Potassium and Sodium Styrene Sulfonate) Its Manufacture and Its Uses  
Antibiotic-associated diarrhea, such as that caused by Clostridium difficile, represents a serious medical complication that can result from administering a broad-spectrum antibiotic to a subject....
US20070190135 Phosphate-binding polymer and tablets using the same  
Disclosed are a phosphate-binding polymer having a true specific gravity of 1.18-1.24, tablets that solely consist of the particles of a phosphate-binding polymer having an average particle size...
US20100074858 Novel iodinated resin manufacturing process and product  
The invention provides a novel method for manufacturing iodinated resin particulates that have widespread utility as disinfectants. The invention also provides novel iodinated demand disinfectant...
US20100272768 COMPOSITIONS AND METHODS FOR CELL KILLING  
A solid buffer including one or more ion exchange materials, wherein said solid buffer has a volumetric buffering capacity greater than about 20 mM H+/(L.pH unit) and further wherein, when said...
US20060051313 Cosmetic composition comprising polymers having a star structure, the polymers, and their use  
A composition capable of being applied to the hair, comprising, in a cosmetically acceptable medium, at least one polymer with a highly specific ordered structure is disclosed. A process for...
US20110236340 CROSSLINKED CATION EXCHANGE POLYMERS, COMPOSITIONS AND USE IN TREATING HYPERKALEMIA  
The present invention is directed to crosslinked cation exchange polymers comprising a fluoro group and an acid group, pharmaceutical compositions of these polymers, compositions of a linear...
US20130189216 LINEAR POLYOL STABILIZED POLYFLUOROACRYLATE COMPOSITIONS  
The present invention is directed to compositions of a linear polyol and a salt of a crosslinked cation exchange polymer comprising a fluoro group and an acid group. These compositions are useful...

Matches 1 - 50 out of 89 1 2 >